Cognition Therapeutics, Inc. (CGTX)
NASDAQ·Healthcare·Biotechnology
$0.96
-1.97%
Mkt Cap $89.13M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+211.9%
Consensus $3.00 vs current $0.96
NASDAQ·Healthcare·Biotechnology
$0.96
-1.97%
Mkt Cap $89.13M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+211.9%
Consensus $3.00 vs current $0.96